hesperetin has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, AK; Navik, U; Sheokand, S | 1 |
| Choi, EJ; Kim, GH | 1 |
2 other study(ies) available for hesperetin and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Nanocrystalline solid dispersions (NSD) of hesperetin (HRN) for prevention of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in Sprague-Dawley (SD) rats.
Topics: Animals; Anthracenes; Female; Hesperidin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Nanoparticles; Piperidines; Random Allocation; Rats; Rats, Sprague-Dawley | 2019 |
Anti-/pro-apoptotic effects of hesperetin against 7,12-dimetylbenz(a)anthracene-induced alteration in animals.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Hesperidin; Mammary Neoplasms, Animal; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Up-Regulation | 2011 |